COMPARISON BETWEEN INSULIN-INDUCED HYPOGLYCEMIA AND GROWTH-HORMONE (GH)-RELEASING HORMONE PLUS ARGININE AS PROVOCATIVE TESTS FOR THE DIAGNOSIS OF GH DEFICIENCY IN ADULTS

Citation
G. Aimaretti et al., COMPARISON BETWEEN INSULIN-INDUCED HYPOGLYCEMIA AND GROWTH-HORMONE (GH)-RELEASING HORMONE PLUS ARGININE AS PROVOCATIVE TESTS FOR THE DIAGNOSIS OF GH DEFICIENCY IN ADULTS, The Journal of clinical endocrinology and metabolism, 83(5), 1998, pp. 1615-1618
Citations number
28
Categorie Soggetti
Endocrynology & Metabolism
ISSN journal
0021972X
Volume
83
Issue
5
Year of publication
1998
Pages
1615 - 1618
Database
ISI
SICI code
0021-972X(1998)83:5<1615:CBIHAG>2.0.ZU;2-R
Abstract
There is now wide consensus that, within an appropriate clinical conte xt, GH deficiency (GHD) in adults must be shown biochemically by provo cative testing of GH secretion and that appropriate cut-off limits hav e to be defined for each provocative test. Insulin-induced hypoglycemi a (ITT) is indicated as the test of choice, and severe GHD, to be trea ted with recombinant human GH replacement, is de fined by a GH peak re sponse to ITT of less than 3 mu g/L. GKRH + arginine (GHRH+ARG) is one of the most promising tests in alternative to ITT. In fact, it has be en reported as a potent, reproducible, and age-independent test and th at it is able to distinguish between GHD and normal adults. The aim of the present study was to compare the GH response to ITT and GHRH+ARG in a large group of hypopituitary adults (n = 40; 29 male and 11 femal e; age: 36.4 +/- 2.1 yr). The third centile limit of the peak GH respo nse to ITT has been reported as 5 mu g/L, whereas in our lab, that to GHRH+ARG is 16.5 mu g/L. In hypopituitary adults, the mean peak GH res ponse to ITT (1.5 +/- 0.2 mu g/L, range: 0.1-8.5 mu g/L)) was lower (P < 0.001) than that to GHRH+ARG (3.0 +/- 0.4 mu g/L, range 0.1-12.0 mu g/L), though there was positive correlation (r = 0.61, P < 0.001) bet ween the GH responses to the 2 tests. The peak GH response to GHRH+ARG , but not that to ITT, was positively (though weakly) associated with insulin-like growth factor-I levels (r = 0.35, P < 0.03). Childhood an d adult onset GKD patients, as well as patients with single and multip le pituitary insufficiencies, had similar peak GH responses to ITT or GHRH+ARG. Analyzing individual GH responses, 4/40 (10%) of the hypopit uitary patients had GH peaks higher than 5 mu g/L after ITT; moreover, 3 other patients (7%) had GH peaks, after ITT, higher than 3 mu g/L. On the other hand, after GHRH+ARG, all patients had GH peaks lower tha n 16.5 mu g/L, whereas 21/40 (52.5%) had GK peaks higher than 3 mu g/L . Because 3 mu g/L is the arbitrary cut-off for ITT, the third centile limit of which is 5 mu g/L, we arbitrarily considered 9 mu g/L as the cut-off point for GHRH+ARG. It is noteworthy that 37/40 (92.5%) patie nts had a GH peak, after GHRH+ARG, below this limit. In conclusion, ou r present results confirm that the ITT test is a reliable provocative test for the diagnosis of adult GKD, whereas they show that the GHRH+A RG test is, at least, as sensitive as the ITT test (provided that appr opriate cut-off limits are considered). Note that even the arbitrary c ut-off point below which severe GHD is demonstrated has to be appropri ate to the potency of the test.